03.12.2012 Views

strategic-management

strategic-management

strategic-management

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EXHIBIT 7 Overview of Direct Competitors<br />

Pfizer Merck Novartis Industry<br />

Market Cap 97.13B 52.31B 86.79B 73.99M<br />

Employees 80,250 54,100 98,000 335<br />

Revenue 47.32B 23.41B 42.29B 253.49M<br />

Gross Margin 85.86% 76.03% 73.10% 71.00%<br />

Operat. Margins 36.13% 25.53% 21.60% 5.89%<br />

Net Income 7.96B 5.93B 7.79B N/A<br />

EPS 1.193 2.785 3.43 N/A<br />

Source: Company Form 10k Reports.<br />

EXHIBIT 8 Pfizer’s Product Patent Expiration<br />

Information<br />

U.S. Basic Product Patent<br />

Drug Expiration Year<br />

Aricept 2010<br />

Lipitor 2010<br />

Xalatan 2011<br />

Geodon 2012<br />

Viagra 2012<br />

Detrol 2012<br />

Celebrex 2014<br />

Zyvox 2015<br />

Lyrica 2018<br />

Chantix 2020<br />

Selzentry 2021<br />

Sutent 2021<br />

Source: SEC Form 10K, February 27, 2009.<br />

EXHIBIT 9 Pfizer’s Mission and Vision in<br />

Emerging Markets<br />

Source: www.pfizer.com.<br />

CASE 25 • PFIZER, INC. — 2009 249

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!